Lumos Pharma Inc.
(LUMO)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -34.03M | -31.06M | -30.43M | -5.66M | -42.99M | -53.59M | -71.95M | -85.16M | -40.38M | 102.86M | -31.18M | -23.32M | -18.09M | -16.56M | -9.68M | -9.16M |
| Depreciation & Amortization | 44.00K | 49.00K | 203.00K | 584.00K | 1.09M | 1.15M | 1.41M | 2.08M | 1.59M | 1.10M | 891.00K | 788.00K | 687.00K | 655.00K | 303.00K | 294.00K |
| Stock-Based Compensation | 2.32M | 2.32M | 2.88M | 1.07M | 6.72M | 17.12M | 18.51M | 16.71M | 15.94M | 8.61M | 4.37M | 3.19M | 2.54M | 1.52M | 661.00K | 141.00K |
| Other Working Capital | 679.00K | 400.00K | -950.00K | -422.00K | 2.62M | 10.32M | 19.10M | -27.91M | -1.48M | -11.40M | 463.00K | -471.00K | 1.27M | 270.00K | -158.00K | 198.00K |
| Other Non-Cash Items | -392.00K | -26.00K | 14.00K | -5.87M | 371.00K | 102.00K | 126.00K | -397.00K | 15.94M | 8.61M | 4.37M | 3.19M | -1K | 1.02M | 661.00K | 5.00K |
| Deferred Income Tax | - | - | - | -9.50M | - | - | - | 3.96M | -15.94M | -8.61M | -4.36M | -3.16M | 1K | 350.00K | -661.00K | - |
| Change in Working Capital | 965.00K | 2.10M | -2.31M | -3.62M | 4.59M | -2.71M | 3.63M | -3.14M | -1.24M | -3.50M | 104.00K | -1.17M | 1.91M | -258.00K | -429.00K | -163.00K |
| Operating Cash Flow | -31.09M | -26.62M | -29.65M | -23.00M | -30.21M | -37.94M | -48.28M | -65.95M | -24.09M | 109.07M | -25.82M | -20.47M | -12.95M | -13.27M | -9.14M | -8.88M |
| Capital Expenditures | - | -21.00K | -30.00K | -30.00K | -2.00K | -7.00K | -43.00K | -2.25M | -4.00M | -1.70M | -1.39M | -1.32M | -281.00K | -2.93M | -1.40M | -427.00K |
| Acquisitions | - | - | - | 84.18M | - | 124.00K | 254.00K | - | - | 12.14M | -1.25M | -946.00K | 762.00K | - | - | - |
| Purchase of Investments | -7.38M | -11.34M | - | - | - | - | - | - | - | -17.38M | -249.00K | -1.99M | -2.49M | -277.00K | - | - |
| Sales Maturities Of Investments | 18.12M | - | - | - | - | - | - | 2.18M | 10.21M | 5.23M | 1.49M | 2.99M | 2.27M | - | - | - |
| Other Investing Acitivies | - | -11.34M | 26.00M | 32.50M | 79.00K | 124.00K | 254.00K | -66.00K | 6.22M | -12.14M | 1.25M | 996.00K | -762.00K | 500.00K | -142.00K | -2.70M |
| Investing Cash Flow | 10.74M | -11.36M | 25.97M | 116.65M | 77.00K | 117.00K | 211.00K | -66.00K | 6.22M | -13.84M | -141.00K | -277.00K | -502.00K | -2.71M | -1.54M | -3.13M |
| Debt Repayment | - | - | - | -27.00K | - | -167.00K | -246.00K | -257.00K | -194.00K | -90.00K | -215.00K | 227.00K | -218.00K | 940.00K | -9.00K | - |
| Common Stock Repurchased | -1.31M | -675.00K | -114.00K | - | -36.00K | -275.00K | -289.00K | -82.00K | -561.00K | -222.00K | - | -4.00K | 13.00K | -468.00K | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | -1K | -1K | - | - | - |
| Other Financial Acitivies | 9.00K | -146.00K | -114.00K | 102.00K | 58.00K | 294.00K | 1.41M | 2.22M | 10.31M | 6.63M | 858.00K | 1.13M | 5.00M | 8.78M | 19.62M | 17.91M |
| Financial Cash Flow | -576.00K | -821.00K | -192.00K | 75.00K | -59.00K | -148.00K | 75.29M | 1.88M | 23.09M | 33.89M | 67.00M | 1.51M | 42.37M | 11.33M | 19.63M | 17.93M |
| Net Cash Flow | -20.93M | -38.80M | -3.87M | 93.73M | -30.19M | -37.97M | 27.22M | -64.13M | 5.22M | 129.11M | 41.04M | -19.24M | 28.92M | -4.64M | 8.94M | 5.92M |
| Free Cash Flow | -31.09M | -26.64M | -29.68M | -23.03M | -30.21M | -37.95M | -48.32M | -68.19M | -28.08M | 107.37M | -27.20M | -21.79M | -13.23M | -16.20M | -10.54M | -9.31M |